Core Insights - Carlyle Group Inc. reported an earnings per share (EPS) of $1.01, slightly below the estimated $1.03, while revenue reached approximately $1.09 billion, surpassing the estimated $1.07 billion [1][6] Financial Performance - The fourth-quarter results showed fee-related earnings growing by 12% year-over-year, reaching a record $1.2 billion, which doubled the firm's original goal [2] - Fourth-quarter distributable earnings increased by 14% from the previous year, amounting to $436 million [2] Fundraising and Capital Deployment - Carlyle raised $53.7 billion in fresh capital during 2025, supported by its credit and AlpInvest platforms [3] - The firm deployed $54.5 billion over the same period and generated $34 billion from asset sales, including the IPO of Medline [3] Financial Metrics - The company has a price-to-earnings (P/E) ratio of approximately 31.96, indicating investor confidence [4] - The price-to-sales ratio stands at about 5.73, reflecting the market's valuation of its revenue [4] - The enterprise value to operating cash flow ratio is negative at -12.56, suggesting challenges in cash flow generation [4] Leverage and Returns - Carlyle's debt-to-equity ratio is 2.25, highlighting its financial leverage [5] - The earnings yield is approximately 3.13%, providing insight into the return on investment for shareholders [5]
Carlyle Group Inc. (NASDAQ:CG) Earnings Report Highlights